Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pressure Biosciences Inc (OP:PBIO)

0.0031 -0.0020 (-39.22%)
Streaming Delayed Price Updated: 12:23 PM EDT, Apr 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,360
Open 0.0031
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0051
Today's Range 0.0031 - 0.0031
52wk Range 0.0005 - 0.2800
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Vita-Forte Collaborate to Commercialize Highly Potent UST Nanoemulsion Oral Spray
Via Investor Brand Network
BioMedNewsBreaks — Pressure BioSciences Inc. (PBIO) to Host Business and Financial Update Teleconference
Via Investor Brand Network

Performance

YTD
-38.0%
-38.0%
1 Month
-31.1%
-31.1%
3 Month
-22.5%
-22.5%
6 Month
-79.3%
-79.3%
1 Year
-98.7%
-98.7%

More News

Read More
BioMedNewsBreaks — Pressure BioSciences Inc. (PBIO) Schedules Business, Financial Update
Via Investor Brand Network
BioMedNewsBreaks — Pressure BioSciences Inc. (PBIO) Subsidiary Plans Expansion to Successful New Premium Collection
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Subsidiary Reports Initial Offering in Uncle Bud’s New Premium Collection Sees ‘Enthusiastic Customer Response’
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Reports Significant Success with Recent Acquisition
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Consolidate All Operations in New Boston-Based Facility
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces New UB Product Line, Plans Investor Teleconference
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Upcoming Investor Teleconference to Discuss Key Company Milestones
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Closes on Acquisition of Uncle Bud’s in All-Stock Transaction
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures New Client Launching Around UltraShear(TM) Nanoemulsions Platform
Via Investor Brand Network
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Eyes Tremendous Opportunity Through Strategic Merger, UltraShear
Via Investor Brand Network
Toni Braxton Cheers PBIO's Acquisition Of Cannabis And Hemp Co. Uncle Bud's
Via Benzinga
Topics Cannabis
Exposures Cannabis
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Moves to Acquire Uncle Bud’s, Accelerate UltraShear(TM) Technology into Multiple Markets
Via Investor Brand Network
Hemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025
Via FinancialNewsMedia
Topics Cannabis
Exposures Cannabis
Hemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025
From FN Media Group LLC
Via GlobeNewswire
Pressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud’s, Forward Integrating PBIO’s UltraShear Platform into Multiple Markets
Via FinancialNewsMedia
Topics Intellectual Property
Exposures Intellectual Property
Pressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud’s, Forward Integrating PBIO’s UltraShear Platform into Multiple Markets
From Pressure BioSciences, Inc.
Via Business Wire
Pressure BioSciences’ BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UltraShear(TM) Platform Featured in Food Technology Article
Via Investor Brand Network
Pressure BioSciences' Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing Platform
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Notes Publication of Report Showing Potential for Proprietary UltraShear(TM) Platform
Via Investor Brand Network
Pressure BioSciences’ UltraShear Platform Maintains Nutritional, Sensory, and Other Important Qualities of Liquid Foods While Inactivating Foodborne Bacterial Spores
Via ACCESSWIRE
InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO), Veterans Service Team Announce Launch of ‘Valor CBD’
Via Investor Brand Network
Pressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST Ambassador
Via ACCESSWIRE

Frequently Asked Questions

Is Pressure Biosciences Inc publicly traded?
Yes, Pressure Biosciences Inc is publicly traded.
What exchange does Pressure Biosciences Inc trade on?
Pressure Biosciences Inc trades on the OTC Traded
What is the ticker symbol for Pressure Biosciences Inc?
The ticker symbol for Pressure Biosciences Inc is PBIO on the OTC Traded
What is the current price of Pressure Biosciences Inc?
The current price of Pressure Biosciences Inc is 0.0031
When was Pressure Biosciences Inc last traded?
The last trade of Pressure Biosciences Inc was at 04/22/25 12:23 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.